Horizon Therapeutics Stock Surges On $28.5 Billion Amgen Takeover
"The acquisition of Horizon is a compelling opportunity for Amgen and the potential new medicines in Horizon's pipeline strongly complement our own R&D portfolio," said Amgen CEO R…
"The acquisition of Horizon is a compelling opportunity for Amgen and the potential new medicines in Horizon's pipeline strongly complement our own R&D portfolio," said Amgen CEO R…